— Know what they know.
Not Investment Advice

VSMD OTC

Vasamed, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -90.0% 5Y: -99.2%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 49 · $802 mcap · 8M float · 0.0008% daily turnover

Balance Sheet Trends

Total Assets
$2M +56.7% ▲
5Y CAGR: -10.0%
Total Liabilities
$1M -78.7% ▼
5Y CAGR: -10.2%
Shareholders Equity
$595K +116.1% ▲
5Y CAGR: -9.7%
Cash & Investments
$1K -84.8% ▼
5Y CAGR: -69.4%
Total Debt
$23K +0.0% ▲
5Y CAGR: -56.5%
Net Debt
$22K +352.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2001FY2002FY2003FY2004FY2005
— Assets —
Cash$665K$244K$17K$9K$1K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$665K$244K$17K$9K$1K
Net Receivables$41K$416K$198K$185K$480K
Inventory$0$260K$237K$194K$449K
Other Current Assets$0$0$0$0$0
Total Current Assets$737K$1M$465K$399K$970K
Property, Plant & Equip.$146K$288K$165K$202K$253K
Goodwill & Intangibles$578K$665K$641K$411K$368K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$697K$620K$424K$10K$10K
Total Non-Current Assets$1M$2M$1M$623K$631K
Total Assets$2M$3M$2M$1M$2M
— Liabilities —
Accounts Payable$70K$213K$108K$140K$192K
Short-Term Debt$1M$0$0$0$4K
Deferred Revenue$562K$0$0$0$36K
Other Current Liabilities$159K$3M$336K$4M$400K
Total Current Liabilities$2M$3M$610K$5M$986K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$19K
Total Liabilities$2M$3M$610K$5M$1M
— Equity —
Common Stock$132K$32K$32K$36K$38K
Retained Earnings-$75M-$77M-$79M-$85M-$92M
Accumulated OCI$0-$36K-$27K-$17K-$7K
Total Stockholders Equity-$193K-$299K$1M-$4M$595K
Total Liabilities & Equity$2M$3M$2M$1M$2M
— Key Metrics —
Total Debt$1M$0$0$0$23K
Net Debt$824K-$244K-$17K-$9K$22K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms